Watchlist Manager

Watchlist

Price: 17.95 TWD -0.28% Market Closed

Market Cap: NT$1.5B

	GenMont Biotech Inc TWSE:3164	TW
	Chaoda Modern Agriculture Holdings Ltd HKEX:682	HK
K	Key Alliance Group Bhd KLSE:KGROUP	MY
	KK Seiyoken TSE:9734	JP

Balance Sheet

Currency: TWD

	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	9	25	70	298	283	368	330	791	1 023	1 002	543	315	96	177	170	225	192	275	170	134	56	111	104
Cash	9	25	70	298	283	368	330	791	1 023	1 002	0	0	0	177	170	225	192	275	170	134	56	111	104
Cash Equivalents	0	0	0	0	0	0	0	0	0	0	543	315	96	0	0	0	0	0	0	0	0	0	0
Short-Term Investments	135	82	4	4	1	0	0	0	9	0	606	0	191	126	202	702	335	190	252	267	273	315	329
Total Receivables	18	24	72	79	101	110	119	125	51	37	29	32	88	84	79	124	72	46	55	52	40	33	47
Accounts Receivables	18	24	40	36	53	38	26	29	28	19	16	21	61	51	34	61	59	35	45	43	32	26	42
Other Receivables	0	0	32	43	49	73	93	95	23	18	13	11	27	34	46	63	13	12	10	9	8	7	4
Inventory	10	16	13	16	14	8	16	18	14	18	17	54	54	61	68	40	31	35	37	55	88	78	70
Other Current Assets	2	3	4	11	10	8	11	12	15	171	5	11	6	6	5	22	54	50	67	13	9	5	5
Total Current Assets	174	150	163	408	409	494	476	945	1 112	1 227	1 200	412	435	454	524	1 114	684	596	581	522	466	542	555
PP&E Net	125	116	106	96	146	169	172	170	150	129	123	922	887	873	868	399	818	954	1 059	1 113	1 060	1 037	976
PP&E Gross	125	116	106	96	146	169	172	170	150	129	123	922	887	873	868	399	818	954	1 059	1 113	1 060	1 037	976
Accumulated Depreciation	25	39	47	61	74	90	108	128	150	157	172	507	536	558	593	232	250	263	279	335	386	459	526
Intangible Assets	27	23	20	0	0	0	0	0	0	0	0	228	189	5	4	0	0	0	0	0	2	2	2
Goodwill	0	15	12	13	13	13	13	13	13	166	9	114	72	9	9	9	0	0	0	0	0	0	0
Long-Term Investments	8	4	12	2	1	0	57	57	30	43	17	23	24	38	40	85	51	44	35	27	72	73	67
Other Long-Term Assets	1	0	1	2	3	6	7	180	189	15	25	43	28	24	55	51	19	19	23	34	53	55	64
Other Assets	0	15	12	13	13	13	13	13	13	166	9	114	72	9	9	9	0	0	0	0	0	0	0
Total Assets	334 N/A	309 -7%	314 +1%	521 +66%	572 +10%	681 +19%	724 +6%	1 366 +89%	1 493 +9%	1 580 +6%	1 374 -13%	1 742 +27%	1 634 -6%	1 404 -14%	1 500 +7%	1 658 +11%	1 571 -5%	1 613 +3%	1 698 +5%	1 696 0%	1 653 -3%	1 709 +3%	1 665 -3%
Liabilities
Accounts Payable	2	4	5	8	4	5	12	14	6	6	7	38	30	25	25	8	8	7	11	14	8	6	8
Accrued Liabilities	8	9	12	24	30	44	46	62	33	27	0	0	0	0	0	28	24	24	27	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	24
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	3	492	431	0	0	0	0	0	2	2	2	1	5	15	9
Other Current Liabilities	1	2	6	26	14	23	30	52	58	38	97	95	91	88	95	56	55	62	99	145	134	99	89
Total Current Liabilities	11	15	23	57	47	71	88	128	101	563	536	133	121	112	120	92	88	95	139	161	146	140	130
Long-Term Debt	0	0	0	0	0	0	0	0	485	0	0	0	0	0	0	0	31	32	31	33	54	83	78
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	1	12	12	12	9	1	1	1	2	2	2	3	6
Minority Interest	74	40	43	18	22	28	28	31	230	0	0	0	0	0	34	72	63	153	148	146	133	128	119
Other Liabilities	1	0	1	2	0	0	0	500	0	0	0	1	1	0	0	2	2	2	2	2	2	2	2
Total Liabilities	85 N/A	55 -36%	67 +22%	77 +16%	69 -11%	99 +44%	117 +18%	659 +465%	816 +24%	563 -31%	537 -5%	145 -73%	133 -8%	124 -7%	163 +31%	168 +3%	186 +11%	284 +52%	322 +13%	344 +7%	337 -2%	357 +6%	334 -6%
Equity
Common Stock	300	327	328	447	449	502	493	541	526	609	609	889	889	889	889	889	889	863	864	864	865	865	860
Retained Earnings	56	90	85	20	49	70	104	180	106	82	47	373	98	236	48	204	128	91	155	118	90	128	113
Additional Paid In Capital	4	18	4	17	4	33	32	8	46	325	301	1 100	727	631	397	398	399	387	376	376	377	354	352
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	1	0	0	0	19	5	2	0	0	0	0	0	0	0	0
Treasury Stock	0	0	0	0	0	22	22	22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Equity	0	0	0	0	0	0	0	0	0	0	25	1	0	0	5	1	32	11	18	6	16	5	6
Total Equity	249 N/A	255 +2%	247 -3%	444 +80%	503 +13%	582 +16%	608 +4%	707 +16%	677 -4%	1 016 +50%	837 -18%	1 597 +91%	1 500 -6%	1 280 -15%	1 337 +4%	1 491 +11%	1 385 -7%	1 329 -4%	1 376 +4%	1 351 -2%	1 316 -3%	1 352 +3%	1 331 -2%
Total Liabilities & Equity	334 N/A	309 -7%	314 +1%	521 +66%	572 +10%	681 +19%	724 +6%	1 366 +89%	1 493 +9%	1 580 +6%	1 374 -13%	1 742 +27%	1 634 -6%	1 404 -14%	1 500 +7%	1 658 +11%	1 571 -5%	1 613 +3%	1 698 +5%	1 696 0%	1 653 -3%	1 709 +3%	1 665 -3%
Shares Outstanding
Common Shares Outstanding	28	29	30	50	50	54	53	53	53	61	61	89	89	89	89	89	89	86	86	86	87	87	86

Income Statement Balance Sheet Cash Flow Statement

GenMont Biotech Inc
TWSE:3164

Balance Sheet

Balance Sheet Decomposition
GenMont Biotech Inc

Balance Sheet
GenMont Biotech Inc

See Also

Company

Help

Tools

Stocks

GenMont Biotech Inc TWSE:3164

Balance Sheet

Balance Sheet Decomposition GenMont Biotech Inc

Balance Sheet GenMont Biotech Inc

See Also

Company

Help

Tools

Stocks

GenMont Biotech Inc
TWSE:3164

Balance Sheet Decomposition
GenMont Biotech Inc

Balance Sheet
GenMont Biotech Inc